🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

29 recruiting trials

for Lupus or SLE

Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease NCT07077486Phase 41 site📍 Wuhan Tongji Hospital · Tests: Methylprednisolone (Corticosteroid), Immunosuppressant other than CYC, Telitacicept Freeze-dried powder Injection 80mg,… Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) NCT06350110Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: CD19- BCMA CAR-T cells Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor NCT05508009Phase 1, Phase 21 site📍 Palo Alto Alice Bertaina · Tests: Cyclophosphamide 1200 mg/Kg, Fludarabine, Cyclophosphamide 100 mg/Kg, Total Body Irradiation, ATG NK010 or NK042 in Combination With Rituximab for Refractory Systemic Lupus Erythematosus/Lupus Nephritis NCT06676631Phase 11 site📍 Guangzhou Guangdong Provincial People's Hospital · Tests: NK 010 or NK042, Rituximab An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases NCT07174843EARLY Phase 11 site📍 Shanghai Shanghai Cell Therapy Group Co.,Ltd · Tests: CD19/CD22/BCMA CAR-T cells(BZE2204) A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus NCT07260877Phase 234 sites📍 Beverly Hills📍 Clearwater📍 DeBary Ventus Therapeutics U.S., Inc. · Tests: VENT-03, Placebo Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension). NCT06133972Phase 3164 sites📍 Anniston📍 Burbank📍 La Palma Novartis Pharmaceuticals · Tests: Placebo, Ianalumab To Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis NCT07629583Phase 12 sites📍 Toulouse📍 Seville Genentech, Inc. · Tests: Cevostamab, Tocilizumab A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease NCT07332481Phase 360 sites📍 Los Angeles📍 Thousand Oaks📍 Cooper City EMD Serono Research & Development Institute, Inc. · Tests: Enpatoran, Placebo, Standard of care (SoC) A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004) NCT07363590Phase 121 sites📍 Southport📍 Diepenbeek📍 Ghent Merck Sharp & Dohme LLC · Tests: MK-1045 A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2) NCT07355218Phase 357 sites📍 Upland📍 DeBary📍 Fort Lauderdale EMD Serono Research & Development Institute, Inc. · Tests: Enpatoran, Placebo, Standard of care (SoC) A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis NCT07328581Phase 24 sites📍 Chicago📍 Hawthorne📍 New Hyde Park iCell Gene Therapeutics · Tests: ICG318, BCMA-CD19-IL-15/IL-15 sushi Compound CAR T following lymphodepletion A Study of Intravenous CPTX2309 in Healthy Participants and Participants With Moderate to Severe Rheumatoid Arthritis (RA) or Systemic Lupus Erythematosus (SLE) NCT06917742Phase 13 sites📍 Herston📍 Bayswater📍 Nedlands Capstan Therapeutics · Tests: CPTX2309, CPTX2309 SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus NCT07523542Phase 1, Phase 21 site📍 Shenzhen Beijing Biotech · Tests: Autologous anti-CD19 CAR-T cells, intravenous single infusion at protocol-defined dose level (1 x 10^6 or 3 x 10^6 CAR-… Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab. NCT07330245n/a22 sites📍 Monserrato📍 Cona📍 San Giovanni Rotondo AstraZeneca · Tests: Anifrolumab A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis NCT07598396Phase 224 sites📍 CABA📍 Buenos Aires📍 Salvador Hoffmann-La Roche · Tests: Mosunetuzumab UB-VV410 in Subjects With Active Refractory Systemic Lupus Erythematosus or Lupus Nephritis NCT07109986Phase 11 site📍 Nanjing Nanjing IASO Biotechnology Co., Ltd. · Tests: UB-VV410 A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants NCT06625671Phase 1, Phase 27 sites📍 La Palma📍 Clearwater📍 Orlando DualityBio Inc. · Tests: DB-2304, Placebo, Prednisone A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132 NCT06875960Phase 44 sites📍 Farmington📍 New York📍 Oklahoma City Bristol-Myers Squibb · Tests: BMS-986165 A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA) NCT07276958Phase 110 sites📍 Brisbane📍 Melbourne📍 Beijing Eli Lilly and Company · Tests: LY4298445, LY4298445 Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases NCT06548607EARLY Phase 11 site📍 Bengbu Nanjing Bioheng Biotech Co., Ltd. · Tests: CD19 or CD19-BCMA CAR-T A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis. NCT06916806Phase 138 sites📍 Anniston📍 Birmingham📍 La Jolla AstraZeneca · Tests: AZD5492 Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants NCT07201558Phase 135 sites📍 Birmingham📍 Fullerton📍 Plantation AstraZeneca · Tests: Surovatamig IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy NCT03152058Phase 23 sites📍 New York📍 Salt Lake City📍 Toronto David Ware Branch · Tests: Certolizumab Pegol A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA) NCT07607964Phase 115 sites📍 Anniston📍 Tustin📍 Clearwater AbbVie · Tests: ABBV-519, ABBV-519 CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc) NCT06822881Phase 11 site📍 Beijing Beijing GoBroad Hospital · Tests: CAR-T Therapy Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE) NCT07575347n/a1 site📍 Bucharest Stefan Lujinschi · Tests: Observational assessment Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Systemic Lupus, on the Frequency of Therapeutic Adjustments NCT05927688n/a1 site📍 Strasbourg University Hospital, Strasbourg, France · Tests: Therapeutic management following access by the physician to his patient's ePROs Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis NCT06975787Phase 119 sites📍 San Francisco📍 Rochester📍 Houston Regeneron Pharmaceuticals · Tests: Vonsetamig, Odronextamab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy